- Jan 19, 2022
FDA Approves Rare Pediatric Disease Designation for IMX-110 for Rhabdomyosarcoma
Officials with the FDA have approved a Rare Pediatric Disease Designation for IMX-110 for the treatment of pediatric patients with ...
- Jun 28, 2021
Genetic discovery could help guide treatment for aggressive childhood cancer
A new study could lead to improved decision making in assigning treatments for children with the aggressive cancer rhabdomyosarcoma ...
- Nov 1, 2018
UA targeting rhabdomyosarcoma, a rare pediatric cancer with few treatment options
Rhabdomyosarcoma (RMS) is a rare cancer of the skeletal muscle that primarily affects pediatric patients. After diagnosis, about 3 out of...
- Aug 27, 2018
Integrated analysis finds vulnerabilities to target in a high-risk pediatric tumor
St. Jude Children's Research Hospital investigators have completed the most comprehensive analysis yet of a common pediatric solid tumor,...
- Jul 4, 2018
New tools used to identify childhood cancer genes
Using a new computational strategy, researchers at UT Southwestern Medical Center have identified 29 genetic changes that can contribute...
- Jun 4, 2018
Extended Chemo Extends Life for Children With Rare Cancer
Children suffering from rhabdomyosarcoma, a rare cancer of the muscle tissue, may have better chances for a cure if they have extended...
- Jul 20, 2016
Childhood Cancer Hijacks Cellular Quality Control System to Fuel Growth
A serious childhood cancer takes advantage of a quality control mechanism that usually protects cells from stress-induced damage to...
- Oct 16, 2015
New test could help personalize treatment for common childhood cancer
A new gene test can identify which patients are likely to suffer more aggressive forms of the childhood cancer rhabdomyosarcoma, new...